LY-23 is an orally active alpha-glucosidase inhibitor (Ki = 0.05 µM), with IC50 values of 0.18 µM, 0.14 µM and 0.51 µM against maltase, sucrase and isomaltase, respectively. LY-23 reduces the level of postprandial blood glucose elevation. LY-23 is applicable to research related to postprandial hyperglycemia[1].
Molecular Weight:
505.84
Formula:
C19H27Cl3O7S
Target:
Glycosidase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
